August 2020 – Proactive Investors: One2One Virtual Conference
Preliminary Results Presentation for the year ended 31 March 2020
To view the presentation of the preliminary results for the year ended 31 March 2020 please click here.
A recording of the webcast can be accessed via the following link:
https://webcasting.buchanan.uk.com/broadcast/5f154afa4c167c1215797e02
Association for research in vision and ophthalmology (ARVO) annual meeting 2019 : Jason Commander presentation
Proactive Investors ‘ReNeuron provides encouraging update to phase II eye disease trial’
OIS: Ophthalmology Innovation & Investment – ReNeuron using hRPCs to treat inherited retinal degenerative diseases
ReNeuron signs retinal stem cell exclusivity agreement
2017 AGM Trading Update – Shareholder Presentation
September 2017: Please click here to see the slides accompanying the AGM Trading Update presentation.
CEO Presents at Cell & Gene Investor Day, April 2017, Boston
CFO Michael Hunt Presents at Shares Magazine Investor Evening – 27th October 2016
CEO Presents at the 6th Annual Cell & Gene Partnering Forum on the Mesa 2016
